FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, and may be used for the use of testosterone and 5-HT1A agonist for preparing a drug for treating sexual dysfunction. Said drug is used as required wherein testosterone is released 3.5-5.5 hours before sexual activity, and 5-HT1A agonist is introduced so that effects of the peak amounts of said substances are partially overlapped. What is also presented is the use of testosterone, PDE5 inhibitor and 5-HT1A agonist for preparing the drug for treating sexual dysfunction. There are also presented pharmaceutical compositions and kits.
EFFECT: group of inventions provides reducing the blood testosterone and 5-HT1A agonist levels to physiological values that promotes treating sexual dysfunction both in males, and in females.
17 cl, 4 ex
